Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/02/2000 | WO2000065042A1 P element derived vector and methods for its use |
11/02/2000 | WO2000065038A2 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
11/02/2000 | WO2000065035A1 Telophase enucleated oocytes for nuclear transfer |
11/02/2000 | WO2000065031A1 Human cell line showing stable expression of cytochromes p450 |
11/02/2000 | WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
11/02/2000 | WO2000065025A2 Dna molecules encoding human endothelin converting enzyme 3 |
11/02/2000 | WO2000064954A1 Polymeric encapsulation system promoting angiogenesis |
11/02/2000 | WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf |
11/02/2000 | WO2000064932A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
11/02/2000 | WO2000064488A2 Somatic transgene immunization and related methods |
11/02/2000 | WO2000064471A1 Model membrane systems |
11/02/2000 | WO2000064469A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
11/02/2000 | WO2000064459A1 Cell therapy for chronic stroke |
11/02/2000 | WO2000064458A2 Method for inducing a donor tolerance in the human body |
11/02/2000 | WO2000064377A1 Prosthetic grafts |
11/02/2000 | WO2000042042A3 High affinity inhibitors for target validation and uses thereof |
11/02/2000 | WO2000041516A3 Reagents and methods useful for detecting diseases of the breast |
11/02/2000 | WO2000040739B1 RIBONUCLEOTIDE REDUCTASE LARGE SUBUNIT (R1) cDNA AND USES THEREOF |
11/02/2000 | WO2000040699A3 Astrocytes, their preparation and uses thereof |
11/02/2000 | WO2000039299A3 Streptococcus antigens |
11/02/2000 | WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
11/02/2000 | WO2000039136A3 Human brainiac-5 |
11/02/2000 | WO2000037642A9 Method of enhancing the biological activity of ligands |
11/02/2000 | WO2000037640A9 Compositions and methods for the treatment of tumor |
11/02/2000 | WO2000037504A9 Human monoclonal antibodies to ctla-4 |
11/02/2000 | WO2000028061A9 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
11/02/2000 | WO2000026417A9 Detection of negative-strand rna viruses |
11/02/2000 | WO2000018932A3 Receptor based antagonists and methods of making and using |
11/02/2000 | WO2000008173A9 Identification and functional characterization of a novel ribosomal s6 protein kinase |
11/02/2000 | WO2000006592A9 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
11/02/2000 | WO2000000624A9 Production of urokinase in plant-based expression systems |
11/02/2000 | WO1998042851A8 Plants with modified growth |
11/02/2000 | EP1048736A1 DNA-construct for the tissue specific expression of a blood coagulation factor |
11/02/2000 | EP1048735A1 DNA-construct for the tissue-specific expression of a blood coagulation factor |
11/02/2000 | EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
11/02/2000 | EP1048731A2 Method for cloning and producing the SwaI restriction endonuclease |
11/02/2000 | EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses |
11/02/2000 | EP1048724A1 Human myoblast cell lines and their uses |
11/02/2000 | EP1048298A2 Mixed chimerism and tolerance |
11/02/2000 | EP1047937A1 Screening method for apoptosis and necrosis |
11/02/2000 | EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species |
11/02/2000 | EP1047790A1 Root-specific promoter |
11/02/2000 | EP1047787A1 Human calcineurin b-like protein |
11/02/2000 | EP1047785A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure |
11/02/2000 | EP1047783A1 Gene associated with disease resistance in plants |
11/02/2000 | EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta) |
11/02/2000 | EP1047780A1 Orphan receptors |
11/02/2000 | EP1047777A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
11/02/2000 | EP1047776A2 Therapeutic composition comprising the kal protein and use of the kal protein |
11/02/2000 | EP1047775A1 Hematopoietic signaling factor |
11/02/2000 | EP1047772A1 Secreted proteins and polynucleotides encoding them |
11/02/2000 | EP1047770A1 Histidine kinase |
11/02/2000 | EP1047714A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM |
11/02/2000 | EP1047713A1 Secreted proteins and polynucleotides encoding them |
11/02/2000 | EP1047712A1 Fatty acid synthase mrna binding protein |
11/02/2000 | EP1047711A1 Nucleic acid sequences encoding capsaicin receptors |
11/02/2000 | EP1047710A2 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof |
11/02/2000 | EP1047441A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
11/02/2000 | EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use |
11/02/2000 | EP0790059A4 Means for treating auto-immune diseases and method of treatment |
11/02/2000 | EP0683816B1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
11/02/2000 | EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
11/02/2000 | DE19919242A1 Modulare Zellträgersysteme für dreidimensionales Zellwachstum Modular cell carrier systems for three-dimensional cell growth |
11/02/2000 | CA2406572A1 Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof |
11/02/2000 | CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase |
11/02/2000 | CA2371253A1 Genome sequence and polypepides of pyrococcus abissy, fragment and uses thereof |
11/02/2000 | CA2371220A1 Promoter-transactivator system for inducible high-level mammalian gene expression with the option of cell growth control |
11/02/2000 | CA2371017A1 Cell therapy for chronic stroke |
11/02/2000 | CA2371006A1 Protein-protein interactions |
11/02/2000 | CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase |
11/02/2000 | CA2370541A1 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
11/02/2000 | CA2370467A1 Gluconobacter suboxydans sorbitol dehydrogenase, genes and methods of use thereof |
11/02/2000 | CA2370442A1 Nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity |
11/02/2000 | CA2370387A1 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same |
11/02/2000 | CA2370385A1 Telophase enucleated oocytes for nuclear transfer |
11/02/2000 | CA2370365A1 Human cell line showing stable expression of cytochromes p450 |
11/02/2000 | CA2370195A1 Human membrane-associated proteins |
11/02/2000 | CA2369058A1 Synthetic gene for expressing active retroviral protein in eukaryotes |
11/02/2000 | CA2368253A1 Prosthetic grafts |
11/02/2000 | CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same |
11/02/2000 | CA2367954A1 Dna molecules encoding human endothelin converting enzyme 3 |
11/01/2000 | CN1272137A Protease variants and compositions |
11/01/2000 | CN1272136A Stimulation of hematopoietic cells in vitro |
11/01/2000 | CN1058054C Process for producing taxane diterpene and method of harvesting cultred cell capable of producing taxane diterpene in high yield |
10/31/2000 | US6140554 Specificity of gene expression |
10/31/2000 | US6140553 Incubating culture of monocotyledonous plant cells on medium including plant phenolic compound to stimulate cell division and enhance competence, then contacting with dna fragment for transformation and stable insertion into the genome |
10/31/2000 | US6140488 Ras-binding protein (PRE1) |
10/31/2000 | US6140486 Isolated nucleic acid having a defined nucleotide sequence from vibrio marinus; for production docosahexanoic acid in transgenic plants; nutrients; dietetics |
10/31/2000 | US6140473 Antibodies specific for MTS2 Polypeptide |
10/31/2000 | US6140467 Ligand for herpes simplex virus entry mediator and methods of use |
10/31/2000 | US6140128 Mixing calcium divalent cation, phosphate multivalent anion and the desired nucleic acid to form precipitation mixture, then incubating for 10 to 60 minutes to form particles |
10/31/2000 | US6140124 Nucleotide sequences which target untranslated regions, translation start site and translation termination position; for diagnosis and treatment of tumors, inflammation and arthritis; antitumor agents; inflammatory agents |
10/31/2000 | US6140122 Kits containing compositions which can be used as internal controls in order to control the different stages of the process, particularly to control the contents of monocytes and other constituents of the starting composition |
10/31/2000 | US6140121 Contacting sample containing sperm with solution comprising hexuronic acid monomer or with solution comprising polymer comprising hexuronic acid and arabinose or galactose to form a mixture, separating sperm |
10/31/2000 | US6140119 Expression of estrogen receptors in type I and type II human breast epithelial cells |
10/31/2000 | US6140118 Avian blastodermal cell lines |
10/31/2000 | US6140117 Ninjurin |
10/31/2000 | US6140116 Adjusted swine neuronal cells for the treatment of humans with stroke, brain trauma, amyotrophic lateral sclerosis, multiple sclerosis, huntington's and alzheimer's disease |
10/31/2000 | US6140111 Nucleotide sequences utilized for the treatment of genetic disorders in human and animal somatic cells |
10/31/2000 | US6140103 Regulated protein expression in stably transfected mammalian cells |